INTRAOCULAR LYMPHOMA
Clinical trials for INTRAOCULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAOCULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for INTRAOCULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: INTRAOCULAR LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
Engineered T-Cells show promise in lymphoma fight
Disease control OngoingThis early-phase trial tests the safety and best dose of specially modified T-cells (immune cells) given after a stem cell transplant for people with high-risk or returning non-Hodgkin lymphoma. The modified T-cells are designed to recognize and attack cancer cells. The study inv…
Matched conditions: INTRAOCULAR LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Singapore study digs into eye inflammation patterns
Knowledge-focused OngoingThis study looks back at the medical records of 200 people in Singapore with eye inflammation conditions like uveitis and scleritis. Researchers want to learn who gets these diseases, what treatments they receive, and how they do over time. The goal is to better understand these …
Matched conditions: INTRAOCULAR LYMPHOMA
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated May 26, 2026 05:59 UTC